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The Ca2 signal facilitates nuclear translocation of
NFAT through the dephosphorylation of clustered ser-
ine residues in the calcium regulatory domain by the
Ca2/calmodulin-dependent phosphatase calcineurin.
The conformation of dephosphorylated NFAT exposes
the nuclear localization signal for translocation into the
nucleus and masks the nuclear export sequence to keep
the protein in the nucleus. It has been reported that
deletion of some serine-rich motifs masking the nuclear
localization signal results in the translocation of NFAT
into the nucleus, but that the nuclear export sequence
located at the N terminus also needs to be deleted for
NFATx (NFAT4/NFATc3) to exert efficient transactiva-
tion function. Here, we report that deletion of the criti-
cal serine-rich motifs of NFATx leads to a conformation
that efficiently exposes the nuclear localization signal
and that has stronger transcription activity compared
with the fully activated wild-type protein in the pres-
ence of the nuclear export sequence. This also suggests
that the regulation of the transactivation domain by
phosphorylation observed in NFAT1 may not contribute
significantly to the transcription activity of NFATx. The
expression of this constitutively nuclear form of NFATx
in the CD4CD8 T cell line facilitates differentiation
into the CD4 single-positive stage upon stimulation with
phorbol ester. Our data suggest that NFATx is involved
in the regulation of co-receptor expression during dif-
ferentiation into the CD4 single-positive stage.
One of the outputs of the proximal signaling pathways of the
T cell antigen receptor is activation of phospholipase C1.
Phospholipase C1 catalyzes phosphatidylinositol 4,5-bisphos-
phate to produce inositol 1,4,5-triphosphate and diacylglycerol
(1). Inositol 1,4,5-triphosphate is a crucial messenger molecule
in up-regulating cytoplasmic Ca2 concentrations, whereas
diacylglycerol activates the small G protein Ras through bind-
ing to the Ras guanyl nucleotide-releasing protein, the hema-
topoietic cell-specific guanine nucleotide exchange factor, via
the diacylglycerol-binding domain and has a role as a protein
kinase C activator (2). Protein kinase C also contributes to the
activation of Ras. The up-regulation of cytoplasmic calcium
leads to the activation of various Ca2/calmodulin-dependent
enzymes, including the phosphatase calcineurin. One of the
crucial targets of calcineurin is NFAT (nuclear factor of acti-
vated T cells) family members (3, 4). Dephosphorylation of
NFAT family proteins results in nuclear translocation (5–7).
The activation of Ras and the downstream mitogen-activated
protein kinase cascade leads to the activation of AP-1 (activator
protein-1). Many genes including those of various cytokines are
induced by the collaborative activity of NFAT and AP-1.
NFAT transcription activity is regulated by several steps.
One important step is the regulation of intracellular localiza-
tion. NFAT family members harbor two conserved nuclear lo-
calization signals (NLS),1 one in the calcium regulatory domain
and the other in the DNA-binding domain. The location of the
nuclear export sequence (NES) has been identified in both
NFATx (NFAT4/NFATc3) and NFATc (NFAT2/NFATc1) (8, 9).
The NES of NFATx is located within the transactivation do-
main near the N terminus, whereas the NES of NFATc is
mapped near the C terminus of the calcium regulatory domain.
The calcium regulatory domains of NFAT family members har-
bor several conserved motifs containing many serine residues,
the phosphorylation of which is regulated by calcineurin and
various NFAT kinases (10–12). These serine-rich motifs are
the calcineurin-regulated inhibitory sequence (CRI)/serine-rich
region (SRR) and three serine-proline (SP) boxes/repeats (SP1,
SP2, and SP3), which are located in the C terminus of the
CRI/SRR region (13, 14). Deletions or point mutations of serine
residues in these conserved motifs result in increased nuclear
translocation and transcription activation of the promoters car-
rying NFAT sites, suggesting that these serine-rich motifs
mask NLS (12, 13, 15, 16). In the case of NFATx, removal of the
NES in addition to deletion of serine-rich motifs has also been
reported to be required to maintain the NFATx protein in the
nucleus and for it to exert its transcription activity efficiently
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(8). In the case of NFAT1 (NFATp/NFATc2), the nuclear local-
ization of the protein by exposing the NLS results in partial
transcription activity (16). Phosphorylation of specific serine
residues is also required within the transcription activation
domain for the complete transcription activity of NFAT1. In
this work, a constitutively nuclear localizing NFATx mutant
with full transcription activity stronger than that of the wild-
type protein in the absence of Ca2 signals was created by
serially deleting the conserved serine-containing motifs of
NFATx. This mutant harbors an intact NES, indicating that
complete activation of nuclear import activity can overcome
nuclear export activity to facilitate efficient transcription. Fur-
thermore, in contrast to NFAT1, the regulation of the tran-
scription activation domain by phosphorylation may not be
required for the complete transcription activity of NFATx.
NFAT family proteins have been suggested to play crucial
roles in the development of T cells in thymus (17). Utilizing the
calcineurin inhibitors cyclosporin and FK506, the activity of
calcineurin in CD4CD8 thymocytes has been shown to be
important for positive selection and/or negative selection (18–
23). Due to the critical role of NFAT family proteins in the
activation of mature T cells, it has been speculated that the
major targets of calcineurin in thymocytes are NFAT family
proteins. Among NFAT family members, NFATx is most highly
expressed in CD4CD8 cells (24), and NFATx-defective mice
show reduced numbers of CD4CD8 cells (25). This reduction
of the CD4CD8 cell population is presumably due to the
reduced level of anti-apoptotic Bcl-2 protein expression, leading
to their susceptibility to apoptosis (25). This indicates that the
role of NFATx in thymocytes is to up-regulate Bcl-2 expression
in response to the selecting signal to facilitate thymocyte sur-
vival. RLm6 (RL male 6) cells, a CD4CD8 T lymphoma, and
CD4CD8 thymocytes differentiate into CD4 single-positive
cells upon phorbol 12-myristate 13-acetate (PMA) and calcium
ionophore treatment (26, 27). We show that when the consti-
tutively nuclear NFATx mutant was introduced into this cell
line, differentiation into the CD4 single-positive stage was in-
duced in the presence of PMA alone, suggesting that NFATx
plays an important role in the positive selection by regulating
the expression pattern of CD4 and CD8 co-receptors.
EXPERIMENTAL PROCEDURES
Cells—COS-7 cells were grown in Dulbecco’s modified Eagle’s me-
dium supplemented with 10% heat-inactivated fetal calf serum, and
Jurkat cells were grown in RPMI 1640 medium supplemented with 5%
fetal calf serum at 37 °C in an atmosphere containing 5% CO2 (28).
RLm6 cells, an x-ray-induced CD4CD8 T cell leukemia line from
BALB/c mice, were cultured in complete Dulbecco’s modified Eagle’s
medium supplemented with 10% fetal calf serum and antibiotics (29).
RLm6-CN, an RLm6 transfectant expressing the Ca2-independent
form of calcineurin, was obtained as previously described (26).
Plasmids—pMEmNFATx1 is a mammalian expression plasmid that
has been previously described (30). This plasmid contains full-length
murine NFATx1 (mNFATx1) cDNA under the control of the SR pro-
FIG. 1. Deletion constructs of
NFATx1 used in this study. Both a
schematic diagram of various NFATx de-
letion constructs (a) and an alignment of
the deleted amino acid residues of each
construct (b) are shown.
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moter in the pME18S vector and was used for the construction of
plasmids containing various deletions in NFATx1 based on standard
recombinant techniques and PCR methods. To construct pMEmX-
(CRI) and pMEmX-(CRISP12), the XbaI-ScaI fragment in mN-
FATx1 cDNA (positions 440–995) was replaced by PCR fragments
generated from pMEmNFATx1, yielding in-frame truncation at posi-
tions 446–616 and 446–814, respectively. pMEmX-(CRISP1) was
constructed by removing an XbaI-AvrII fragment (positions 440–716),
followed by direct self-ligation. pMEmX-(CRISP12) was processed for
further truncation by replacing the 186-bp XbaI-ScaI fragment in this
plasmid with a 117-bp PCR-generated fragment derived from pMEm-
NFATx1, generating pMEmX-(CRISP123) containing an additional
truncation corresponding to positions 869–937 in the mNFATx1 se-
quence. Nucleotide sequences of junctions and PCR-derived fragments
were verified in all of the plasmids by DNA sequencing. Deduced amino
acid sequences in the corresponding regions of the plasmids are sum-
marized in Fig. 1. In particular experiments, the carboxyl-terminal
domains of wild-type or truncated NFATx1 constructs (corresponding to
positions 2116–3235 in mNFATx1) were replaced with a 720-bp DNA
fragment encoding enhanced green fluorescent protein (EGFP) cDNA,
excised from pEGFP-N1 (CLONTECH, Palo Alto, CA) by ApaI and NotI.
Plasmid pNFAT72-Luc contains the luciferase reporter gene under the
control of three of the murine interleukin (IL)-2 promoter NFAT sites
(positions 290–261) (31). pRL-SV40, a co-reporter plasmid for the
Dual-LuciferaseTM reporter assay, was purchased from Promega (Mad-
ison, WI). pMKITmNFATx and pMKITmNFAT-(CRISP12) contain
wild-type mNFATx cDNA from pMEmNFATx1 and mNFATx lacking
CRI, SP1, and SP2 from pMEmX-(CRISP12), respectively.
Transfection, Cell Stimulation, Cell Extracts, and Western Blotting—
Transient transfection in COS-7 and Jurkat cells was carried out by a
DEAE-dextran method as described previously (24, 28). RLm6 cell
transfectants stably expressing wild-type or truncated forms of
NFATx1 were generated as follows. EcoRI-XhoI fragments encoding the
full-length or truncated forms of NFATx1 cDNA were subcloned into a
mammalian expression vector (pMKIT-Neo) from which the MluI frag-
ment had been excised. pMKITmNFATx, pMKITmNFAT-(CRI), and
pMKITmNFAT-(CRISP12) were thus obtained. The linearized con-
structs were prepared by digestion with NluI. RLm6 cells were trans-
fected with the linearized constructs or control pMKIT-Neo by electro-
poration and selected as previously described (24). RLm6 or its
transfectants were stimulated with PMA (Sigma) and/or ionomycin as
previously described (24) in the presence or absence of FK506 as
indicated.
To prepare the whole cell extracts, cells were harvested at 48 h,
rinsed with phosphate-buffered saline, and then lysed with radioim-
mune precipitation assay buffer containing protease and phosphatase
inhibitors as described (32). The lysates were rotated for 30 min at 4 °C
and centrifuged at 15,000 rpm for 15 min to remove debris. Cytosolic
and nuclear extracts from transfected COS-7 cells were prepared as
described previously (28). These lysates were separated by SDS-PAGE,
transferred to nylon membrane, and blotted with rabbit anti-NFATx
antibody X-75 (13), followed by detection using an ECLTM kit (Amer-
sham Biosciences).
Luciferase Assay—Jurkat cells were maintained in RPMI 1640 me-
dium supplemented with 5% heat-inactivated fetal calf serum, antibi-
otics, and 1 mM L-glutamine at 37 °C in a humidified atmosphere
containing 5% CO2. Luciferase assay was carried out according to the
procedure described previously (13), with minimal modification. Briefly,
3  106 Jurkat cells were transfected with a pME18S-based expression
vector (15 g) and the pNFAT72-Luc reporter plasmid (3 g) (31). For
the control to monitor the efficiency of transfection, the pRL-SV40
Renilla luciferase reporter plasmid (0.25 g) was also included for
transfection. After 40 h of incubation, cells were stimulated with 20
ng/ml PMA with or without 0.5 mM A23187(Calbiochem) for 8 h at 37 °C
in a humidified atmosphere containing 5% CO2, and then the cells were
harvested.
Electrophoretic Mobility Shift Assay (EMSA)—EMSAs were con-
ducted using a double-strand oligonucleotide probe containing the dis-
tal NFAT site from the human IL-2 promoter with 1 g of transfected
COS-7 cytosolic or whole cell extracts. Procedures for EMSAs and the
double-strand oligonucleotides used in this study have been described
previously (24).
Intracellular [Ca2] Measurement—Cultured cells were incubated
with 3 M fura-2/AM (Texas Fluorescence Labs Inc., Austin, TX) for 20
min. Using a fluorometer (CAF-100, Jasco, Tokyo, Japan), the emitted
fluorescence (520 nm) in response to alternate pulses of excitation light
at 340 and 380 nm was monitored for 15 min. Triton X-100 (0.1%) and
EGTA (10 mM) were successively added to the cell suspension to deter-
mine the intracellular Ca2 concentration according to an equation
with a Kd value of 224 nM as described (33). In all tested cells under
unstimulated conditions, the intracellular Ca2 concentration deter-
mined by the fura-2 method was 150 nM (range of 134–170 nM).
RESULTS
Preferential Nuclear Localization of NFATx Proteins Harbor-
ing Deletions of the CRI/SRR, SP1, SP2, and SP3 Motifs—It
has been shown that the calcium regulatory domain includes
critical motifs that regulate subcellular localization of NFAT
proteins. In the case of NFATx, we have previously shown that
when the CRI/SRR motif in its calcium regulatory domain was
truncated, the NFATx protein showed not only enhanced nu-
clear localization, but also transactivation upon PMA-alone
stimulation (13). However, the extent of transactivation by
CRI/SRR-deleted NFATx upon PMA-alone stimulation was
very limited compared with that upon PMA plus calcium iono-
phore stimulation. This prompted us to further modify the
calcium regulatory domain to create constitutively active forms
that show strong transcription activity.
Among conserved motifs in calcium regulatory domain, SP
motifs (SPXXSPXXSPXXXXX(E/D)(E/D)) adjacent to the CRI/
SRR domain are short sequences that have been suggested to
be a target of stimulation-dependent serine phosphorylation/
dephosphorylation of NFAT proteins (5–7, 15). We first exam-
ined the function of NFATx molecules by serial truncation of
the SP motifs in addition to CRI/SRR. Among the multiple
isoforms of NFATx, NFATx1 is the one that is predominantly
expressed in human and murine thymuses that might be in-
volved in thymocyte differentiation (30, 31). In this study,
murine NFATx1 was used for experiments in view of its appli-
cation in murine cells. The residues of the CRI/SRR domain
and SP motifs are almost completely identical between human
and mouse NFATx homologs (30). We first truncated the amino
acid residues corresponding to the CRI/SRR region of murine
NFATx. In addition to this construct, designated X-(CRI), we
generated additional constructs that had serially truncated SP
FIG. 2. Protein expression and subcellular localization of mu-
tant NFATx1 proteins expressed in COS-7 cells. a, detection of
mutant NFATx proteins expressed in whole cell extracts from COS-7
cells transfected with various mutant NFATx constructs by immuno-
blotting; b, detection of mutant NFATx proteins in fractionated cyto-
plasmic (CE) or nuclear (NE) extracts from transfected COS-7 cells by
immunoblotting. Wt, wild-type.
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motifs (Fig. 1, a and b). Residues covering SP1 and SP1/2 were
serially truncated in X-(CRISP1) and X-(CRISP12), respec-
tively. In X-(CRISP123), SP3 was further truncated from
X-(CRISP12), leaving intact amino acid residues between
SP2 and SP3 that have been predicted to contain an NLS (6, 13,
15).
The protein expression levels and subcellular distribution of
these NFATx mutants were examined by transfecting the CRI/
SP-truncated constructs into COS-7 cells, taking advantage of
the efficient separation of nuclear and cytoplasmic protein frac-
tions from these cells. When crude whole cell extracts from the
transfected cells were subjected to immunoblotting (Fig. 2a),
the wild-type or mutant NFATx protein was detected using
specific anti-NFATx antiserum, with different molecular sizes
being consistent with the different lengths of truncation. It was
also notable that truncated molecules, especially in the case of
X-(CRISP123), showed reduced amounts of protein expres-
sion compared with wild-type NFATx.
To examine the subcellular distribution of the mutant
NFATx1 proteins, we next prepared extracts from nuclear and
cytoplasmic fractions from COS cells transfected with these
constructs, followed by immunoblot analysis. As expected, the
wild-type NFATx protein showed highly selective cytoplasmic
sequestration (Fig. 2b, second lane). In contrast, when using
cytoplasmic and nuclear extracts from cells transfected with
X-(CRI), truncated NFATx protein was detected both in cyto-
plasmic and nuclear fractions (Fig. 2b, third lane), consistent
with observations in human NFATx1 protein (13). However,
when one or more SP motifs were truncated, the resultant
NFATx proteins were detected preferentially in the nuclear
fraction, but barely in the cytoplasmic fraction (Fig. 2b, fourth
through sixth lanes). These results are consistent with the
notion that SP motifs, in addition to the CRI/SRR region, are
critical for the regulation of subcellular localization of the
NFATx protein (15, 16).
To analyze the intracellular distribution of the wild-type and
mutant NFATx proteins in individual cells, we generated GFP-
fused constructs of NFATx mutants in which the carboxyl-
terminal domain of each NFATx mutant was replaced with
cDNA encoding GFP (Fig. 3a). When COS cells were trans-
fected with the wild-type NFATx-GFP plasmid, the resultant
NFATx-GFP protein was localized completely in the cytoplasm
of transfected COS cells (Fig. 3a, upper left panel). In contrast,
X-(CRI) showed nuclear distribution, whereas some fluores-
cence was also observed in the cytoplasm (Fig. 3a, upper right
panel). When X-(CRISP1) was transfected, increased nuclear
distribution was observed (Fig. 3a, lower left panel). Interest-
ingly, transfection of the NFATx-GFP mutant lacking SP1 and
FIG. 3. Enhanced nuclear localiza-
tion of mutant NFATx proteins fused
to EGFP in unstimulated COS-7 cells.
a, microscopic display of wild-type (Wt)
and mutant EGFP-fused NFATx1 con-
structs expressed in COS-7 cells; b, nu-
merical representation of the nuclear
localization of EGFP-fused NFATx
mutants. The percentages of cells with
nuclear fluorescence (open bars), both
nuclear and cytoplasmic fluorescence
(hatched bars), and cytoplasmic fluores-
cence (closed bars) out of the 200 cells
positive for EGFP were microscopically
determined. Averages of three independ-
ent experiments are displayed.
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SP2 or all three SP motifs resulted in highly selective nuclear
localization (Fig. 3a, lower middle and right panels). These
results were also obtained when cells were counted for cyto-
plasmic/nuclear fluorescence (Fig. 3b). Thus, serial truncation
of SP motifs enhances nuclear localization of the NFATx
protein.
CRI/SP-truncated NFATx Proteins Are “Conditional” Mu-
tants Showing Efficient Transactivation upon PMA-alone Stim-
ulation—Based on the observation that CRI-truncated NFATx
shows PMA-alone-induced transactivation (13), we examined
the activities of these NFATx mutants in inducing calcium
ionophore-independent transactivation (Fig. 4). Expression
plasmids for wild-type or mutant NFATx proteins were trans-
fected into Jurkat T cells with a reporter plasmid carrying
three tandem copies of NFAT/AP-1 sites, followed by stimula-
tion using PMA or PMA plus A23187. Jurkat cells transfected
with the control pME18S plasmid showed weak NFAT trans-
activation upon stimulation with PMA plus A23187, which
might reflect endogenous NFAT activity. When cells were
transfected with the plasmid encoding wild-type NFATx, in-
creased NFAT activity was observed in the presence of both
PMA and A23187 (Fig. 4, second bar). In contrast, when cells
were transfected with the plasmid encoding X-(CRI), transac-
tivation driven through NFAT sites was observed even after
PMA-alone stimulation, despite the low activity (Fig. 4, third
group of bars). These results are consistent with our previous
observations in human NFATx (13). Moreover, truncation of SP
motifs dramatically increased PMA-alone-induced transactiva-
tion of mutant NFATx constructs. When SP1 was truncated in
addition to CRI/SRR, transactivation was increased (Fig. 4,
fourth group of bars). However, when SP1 and SP2 or all three
SP motifs were truncated, these mutant NFATx constructs
induced significantly increased transactivation upon PMA-
alone stimulation, comparable to the stimulation with both
PMA plus A23187 (Fig. 4, fifth and sixth groups of bars). The
activities of these mutants were much stronger than the wild-
type activity. Thus, CRI/SP deletion in NFATx results not only
in increased nuclear localization, but also in efficient transac-
tivation in the absence of calcium/calcineurin signaling.
Modified DNA Binding of CRI-truncated NFATx Mutants—
The increased transactivation by CRI/SP-truncated mutants of
NFATx could be partially explained by their increased nuclear
distribution (Figs. 2 and 3). However, increased transactivation
might also be caused by the altered affinity of DNA binding by
mutant NFAT molecules. We therefore tested protein-DNA
binding of mutant NFATx using extracts from transfected
COS-7 cells. Because subcellular distribution was very differ-
ent among various NFATx mutants (Fig. 2), whole cell extracts
from transfected COS cells were used for the EMSA analysis.
As shown in Fig. 5a, whole cell extract from COS-7 cells trans-
fected with wild-type NFATx showed an NFAT-DNA-binding
complex that was comparable to the reconstituted NFAT-DNA
complex in cytosolic extract with NFATx1 and exogenous AP-1
(HeLa nuclear extract) (34). NFATx-DNA contained two major
bands. Studies using competitor oligonucleotides indicated that
the upper slow-migrating band represents an NFAT-AP-1 com-
plex, whereas the lower fast-migrating band represents NFAT
without AP-1, consistent with previous studies (24, 35).
NFAT-DNA complexes in cell extracts from COS cells trans-
fected with mutant NFATx molecules were then examined. As
shown in Fig. 5b, when extracts from mutant NFAT transfec-
tants were tested, all extracts showed NFAT-DNA-binding ac-
tivities containing two major protein-DNA complexes. Interest-
ingly, when the extract with X-(CR1) was tested, both the
upper and lower complexes appeared with higher intensities
than in the wild-type NFATx transfectants (Fig. 5b, lanes 1 and
2). In addition, the lower complex appeared with slower mobil-
ities than in the wild-type NFATx transfectant (Fig. 5b, lanes 1
and 2). Because the amount of the expressed X-(CRI) protein
in transfected COS cell extracts was less than that of wild-type
NFATx (Fig. 2a), the increased NFAT-DNA binding of
X-(CRI) may be attributable to modified DNA-binding affin-
ity. Other mutants showed two similar NFAT-DNA complexes
with CRI-truncated mutants with slight mobility differences
that would represent different molecular sizes. X-(CRISP123)
showed reduced intensities of the NFAT protein-DNA complex,
which would be due to reduced protein expression in COS cells
(Fig. 2a). Among CRI/SP-truncated mutants, the extent of SP
deletion did not appear to increase the intensity of the NFAT-
DNA complex, suggesting that truncation of CRI (but not SP
motifs) affects the DNA-binding affinities of these mutants.
CRI/SP-deleted NFATx Mutants Function as Conditionally
Active Mutants Able to Induce Differentiation of CD4CD8 T
Cells upon PMA-alone Stimulation—We wondered whether
NFATx plays an important role in thymocyte positive selection.
Thus, we used these conditionally active mutants of NFATx to
FIG. 4. NFAT transactivation by
various NFATx mutants upon PMA-
alone or PMA plus A23187 stimula-
tion. Jurkat cells were transiently trans-
fected with various mutant NFATx1
constructs or the empty pME18S vector
with the pNFAT72-Luc reporter plasmid.
Cells were incubated for 40 h after trans-
fection and then stimulated for 8 h and
harvested, followed by Dual-Luciferase
assay analyses. The data represent aver-
ages of three independent experiments.
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determine whether NFATx contributes to the differentiation of
a CD4CD8 T cell line. Wild-type or mutant NFATx cDNAs
were ligated to the pMKIT-Neo expression vector, and the
resultant plasmids were transfected into the RLm6 T cell line,
representing the CD4CD8 stage of thymocytes. RLm6 is an
x-ray-induced CD4CD8 T cell line (29) that becomes CD4
single-positive (26) and acquires the CC chemokine receptor
CCR7 (36) upon calcium ionophore ionomycin/PMA stimula-
tion. pMKITmNFATx, pMKITmNFATx-(CRI), and pMKITm-
NFATx-(CRISP12) were used for generating stable transfec-
tants, and 5, 6, and 10 gentamycin-resistant clones were
obtained, respectively (Table I). All of the transfectants re-
tained the CD4CD8 phenotype without stimulation and de-
veloped the CD4 single-positive phenotype after ionomycin/
PMA stimulation, as in the case of parental cells. However, in
the case of cells transfected with CRI/SP-truncated NFATx,
some of the cells showed phenotypic changes to CD4 single-
positive even after PMA-alone stimulation (Table I). Repre-
sentative results of the experiments are shown in Fig. 6. Sim-
ilar to the case of CN, the calcium-independent form of
calcineurin (26), some RLm6 cells transfected with
X-(CRISP12) responded to PMA-alone stimulation and be-
came CD4 single-positive or CD4CD8low. Strikingly, the
PMA-induced differentiation of X-(CRISP12)-transfected
cells was resistant to the action of FK506, whereas that of
CN-transfected cells was markedly inhibited by FK506.
FK506 is a well known inhibitor of thymocyte positive selection
(18, 22, 23) and can inhibit calcineurin activity even in its
calcium-independent form encoded by CN (37).
To confirm that the phenotypic change in RLm6 transfec-
tants was induced by the action of expressed NFATx and not by
an alteration of intracellular Ca2 mobilization, we measured
the intracellular Ca2 concentration of transfectants. As shown
in Table II, there was no significant correlation between the
intracellular Ca2 levels of RLm6 transfectant cells and the
phenotypic changes in the cells.
DISCUSSION
The mechanism of nuclear transport of NFAT family pro-
teins has been extensively studied. Typical NLS sequences are
present in both the calcium regulatory domain and the Rel
similarity domain, which is required for DNA binding. The
location of the NES has been mapped in NFATc and NFATx,
but at different positions (8, 9). Conserved motifs in the calcium
regulatory domain (CRI/SRR, SP1, SP2, and SP3) contain
many serine residues, most of which are phosphorylated in
unstimulated cells (16). The calcium signal dephosphorylates
these serine residues through the activation of calcineurin,
leading to a conformational change in the calcium regulatory
domain to expose NLS and to induce nuclear translocation (15,
16, 38). We have previously shown that deletion of the CRI/SRR
domain makes some of the NFATx protein localize in the nu-
cleus (13, 30). Here, we show that the additional serial deletion
of SP motifs in addition to CRI/SRR induced more striking
nuclear localization. Deletion of CRI/SRR, SP1, and SP2
showed that nearly 90% of cells harbored NFATx completely in
the nucleus, in contrast to deletion of only CRI/SRR, which
gave only 10%. Further deletion of SP3 did not contribute
much to the increased extent of nuclear localization. Transcrip-
tion activity in the presence of PMA measured by the reporter
plasmid carrying the NFAT/AP-1 composite site from the IL-2
gene was proportional to the extent of nuclear localization.
Deletion of CRI/SRR, SP1, and SP2 resulted in maximal activ-
ity upon PMA stimulation, which was higher than that of
wild-type NFATx in the presence of both PMA and ionomycin.
Again, further deletion of SP3 did not show much additional
effect on transcription activity. Zhu and McKeon (8) have re-
FIG. 5. Comparison of NFAT protein-DNA binding of various
NFATx1 constructs expressed in COS-7 cells by EMSA. The DNA-
binding activities of the cytosolic and whole cell extracts of NFATx-
transfected COS cells were compared by EMSA analysis. The nuclear
extract (NE) of HeLa cells contained AP-1 activity (a). Sequence-specific
DNA-binding activities of the whole cell extracts prepared from wild-
type and various mutant NFATx plasmid-transfected COS cells were
analyzed (b).
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ported that the nuclear export activity has to be shut off in
order for NFAT to stay in the nucleus and to exert its tran-
scription activity. They showed that deletion of the region
containing SP1 results in nuclear localization without a cal-
cium signal, although this mutant cannot activate transcrip-
tion efficiently due to the presence of the NES located in the N
terminus. The presence of the NES inhibits the prolonged
localization of the NFAT protein in the nucleus. Deletion of the
NES in addition to the SP1-containing region is required for
NFATx to stay in the nucleus for sufficient time to activate
transcription. The X-(CRISP12) mutant of NFATx retains
the complete NES that Zhu and McKeon mapped, but this
mutant showed strong transcription activity upon PMA treat-
ment. In our experiments, deletion of the SP1 region resulted
in only a small portion of cells with nuclear localization. Fur-
thermore, the NES mapped by Zhu and McKeon overlaps with
the transactivation domain of NFATx. Thus, when the NES is
deleted, part of the transcription activation domain is removed.
The X-(CRISP12) mutant retains an intact NES, but also
retains all of the transactivation domain located in the N ter-
minus; it is therefore presumably efficiently imported into the
nucleus and induces transcription despite the nuclear export
activity mediated through the NES. All this suggests that the
balance of nuclear import and export activities, in addition to
the sum of the strength of all of the transcription activation
domains, contributes to the overall transcription activity of
NFATx.
In the presence of PMA, X-(CRISP12) gave strong tran-
scription activity, which was stronger than that of the wild-
type protein fully activated. Rao and co-workers (16) have
reported that a mutant of NFAT1 with alanine replacement of
all serine residues in the CRI/SRR, SP1, SP2, and SP3 motifs
with a fused NLS derived from SV40 T antigen shows almost
complete nuclear localization and strong transcription activity
in the presence of AP-1. However, the transcription activity of
this mutant is still weaker than that of the wild-type protein
fully activated. They then showed that the serines in the SSPS
motif located in the transactivation domain very close to the N
terminus are phosphorylated upon stimulation. Furthermore,
a Gal4 fusion protein with this N-terminal region showed
stimulation-dependent transcription activation, in which these
serine residues played a crucial role. The transactivation do-
mains located in the N terminus are not conserved among
NFAT family members. The SSPS motif is not present in this
TABLE I
Phenotypic changes in RLm6 cells transfected with full-length or truncated NFATx upon stimulation
Construct Established clonenumbersa
CD4 single-positive differentiation upon stimulationb
PMA alone PMA  ionomycin
pMKITmNFATx 5 0 (0%) 5 (100%)
pMKITmNFATx-(CRI) 6 2 (33%) 6 (100%)
pMKITmNFATx-(CRI  SP12) 10 8 (80%) 10 (100%)
a RLm6 cells were transfected with full-length or truncated NFATx, and gentamycin-resistant clones were obtained.
b Transfectant clones were stimulated with 0.2 ng/ml PMA alone or with a combination of 0.2 ng/ml PMA and 0.2 g/ml ionomycin for 48 h and
then analyzed for CD4/CD8 expression.
FIG. 6. Stimulation-dependent phenotypic changes in the RLm6 T cell line transfected with various NFATx constructs. Stable
transfectants with NFATx-(CRISP12) (Lm6 DNFATx), CN (RLm6 DCN), and the control vector (Control) were stimulated under various
conditions for 48 h, and the expression of CD4 and CD8 co-receptors was analyzed by flow cytometry. The concentrations of PMA, ionomycin (IM),
and FK506 were 0.2 ng/ml, 0.2 g/ml, and 10 nM, respectively.
TABLE II
Intracellular Ca2 levels in RLm6 cells transfected with
truncated forms of NFATx
RLm6 and its transfectants were incubated with fura-2/AM. After
washing, the cells were analyzed for intracellular Ca2 levels by meas-
uring fluorescence intensity. ND, not done.
Transfected DNA
Intracellular Ca2 level
Exp. 1 Exp. 2
nM
None 143.7 ND
pMKIT-Neo 169.8 134.4
pMKITmNFATx-(CRI  SP12) 165.8 153.9
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region of NFATx. Thus, in contrast to NFAT1, NFATx can have
full transcription activity without such a mechanism. The ki-
nase that phosphorylates the SSPS motif of NFAT1 has not
been identified, but an interesting possibility is that in cells
that have little or no activity of this kinase, NFATx may play a
more dominant role among NFAT family members, especially
for genes with promoters harboring AP-1-independent regula-
tory regions. This could be one of the mechanisms that contrib-
utes to the functional differences of each NFAT family protein.
Another interpretation for this difference between NFATx and
NFAT1 might be the difference of the promoters used to meas-
ure NFAT activity in these experiments. Rao and co-workers
used the IL-13 promoter to measure NFAT1 activity, whereas
we used the promoter with the NFAT/AP-1 composite site from
IL-2.
NFAT family proteins have been shown to play important
roles in T cell development in thymus. NFAT proteins are
important signaling molecules that mediate positive selection.
NFAT family proteins appear to contribute successively to thy-
mocyte differentiation (34). There are some reports suggesting
that NFAT proteins are also involved in negative selection,
although this is a controversial issue (19–21, 39). Recently, the
important role of NFAT in  selection has been reported (40).
However, all these reports utilized a calcineurin inhibitor (cy-
closporin or FK506) to analyze the involvement of NFAT pro-
teins. We have previously reported that NFATx is the major
subtype in the CD4CD8 cell population among NFAT family
members (24, 34). The number of total thymocytes and the
ratio of the CD4CD8 population in NFATx-disrupted mice
are decreased, suggesting the important role of NFATx in thy-
mocyte development (25). CD4CD8 cells undergoing thymic
selection and single-positive cells in NFATx-disrupted mice
express reduced levels of anti-apoptotic protein Bcl-2, thereby
failing to support the survival of positively selected cells, lead-
ing to their apoptosis. However, the role of Bcl-2 in positive and
negative selection is still under debate (41). We have shown
here that the X-(CRISP12) mutant of NFATx differentiated
CD4CD8 cells into CD4 single-positive cells in the presence
of PMA alone in the CD4CD8 cell line RLm6 and that this
effect of the NFATx mutant was resistant to the calcineurin
inhibitor FK506. We have shown that differentiation of
CD4CD8 cells to CD4 single-positive cells could be induced
by PMA and calcium ionophore treatment or by PMA treat-
ment alone in the presence of constitutively active calcineurin
(CN) (26). The effect of the calcineurin mutant was inhibited
by FK506. These data suggest that one of the crucial targets of
calcineurin in the CD4CD8 stage is NFATx. Indeed, NFATx
significantly contributes to an early rise in the DNA-binding
activity of NFAT during the differentiation of CD4CD8 thy-
mocytes in vitro (34). Therefore, NFATx should be involved in
the differentiation of CD4CD8 thymocytes to CD4 single-
positive cells during positive selection not only by up-regulat-
ing the expression of Bcl-2, but also by modulating the expres-
sion of the co-receptors, CD4 and CD8. This is the first evidence
that shows the role of NFATx in the differentiation of
CD4CD8 cells utilizing the NFATx molecule itself.
The NFAT family members and NF-B family members
show structural similarity and play crucial roles in the tran-
scription of various genes, including many cytokine genes,
upon activation of immune and inflammatory cells. In addition,
both transcription factor families are suggested to be required
for thymic development. The requirement of NF-B activity for
efficient positive selection has been shown by suppression of
the activation of all NF-B family proteins through the over-
expression of the super-inhibitor IB. IB harbors mutations in
the critical serine residues that are phosphorylated upon stim-
ulation and that are required for IB degradation. Thus, cells
expressing IB become resistant to the signal that activates all
members of the NF-B family. In IB transgenic mice, positive
selection of CD8 single-positive thymocytes is impaired (42).
The overexpression of IB in the CD4CD8 cell line DPK
inhibits differentiation into CD4 single-positive cells induced
by antigen stimulation (43). Although the transcription regu-
latory elements present in the CD8 cluster region and the CD4
locus have been extensively analyzed, NFAT or NF-B sites
have not been identified as critical regulatory elements. Utiliz-
ing mutant NFATx and the CD4CD8 cell line, we can shed
light on the relationship between the transcription factors that
directly regulate promoters and enhancers of the co-receptor
genes and NFATx during thymic selection.
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